Literature DB >> 24177043

Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.

Yanxia Chu1, Ai Zheng, Fei Wang, Wei Lin, Xiaoyun Yang, Ling Han, Yali Chen, Liping Bai.   

Abstract

OBJECTIVES: Accurate detection of recurrent cervical cancer remains a clinical difficulty. This study aims to assess the diagnostic value of PET or PET-computed tomography (PET-CT) using F-fluorodeoxyglucose (F-FDG) in recurrent cervical cancer using a meta-analysis. STUDY
DESIGN: All published studies in English evaluating the diagnostic value of PET or PET-CT in detecting recurrent cervical cancer were collected. The methodological quality of the included studies was evaluated. Pooled sensitivity, specificity, diagnostic odds ratio, and summary receiver-operating characteristic curves were obtained using statistical software. Twenty studies were included in the meta-analysis.
RESULTS: The meta-analysis showed that the pooled sensitivity and specificity of PET and PET-CT to detect distant metastasis in recurrent cervical cancer were 0.87 [95% confidence interval (CI): 0.80-0.92] and 0.97 (95% CI: 0.96-0.98), respectively. The pooled sensitivity and specificity for local regional recurrence were 0.82 (95% CI: 0.72-0.90) and 0.98 (95% CI: 0.96-0.99), respectively.
CONCLUSION: F-FDG-PET and PET-CT are valuable methods for the assessment of recurrent cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24177043     DOI: 10.1097/MNM.0000000000000026

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  8 in total

Review 1.  Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Authors:  Yulia Lakhman; Stephanie Nougaret; Maura Miccò; Chiara Scelzo; Hebert A Vargas; Ramon E Sosa; Elizabeth J Sutton; Dennis S Chi; Hedvig Hricak; Evis Sala
Journal:  Radiographics       Date:  2015 Jul-Aug       Impact factor: 5.333

2.  SEOM clinical guidelines for cervical cancer (2019).

Authors:  A de Juan; A Redondo; M J Rubio; Y García; J Cueva; L Gaba; A Yubero; J Alarcón; C Maximiano; A Oaknin
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

3.  Local Radiotherapy or Chemotherapy for Oligo-recurrent Cervical Cancer in Patients With Prior Pelvic Irradiation.

Authors:  Kazuma Kobayashi; Naoya Murakami; Kana Takahashi; Koji Inaba; Ryuji Hamamoto; Jun Itami
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

Review 4.  Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.

Authors:  Kazuhiro Kitajima; Yasuhiko Ebina; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2014-04-18       Impact factor: 2.374

Review 5.  The role of imaging in pelvic exenteration for gynecological cancers.

Authors:  Pamela Ines Causa Andrieu; Sungmin Woo; Eric Rios-Doria; Yukio Sonoda; Soleen Ghafoor
Journal:  Br J Radiol       Date:  2021-05-07       Impact factor: 3.629

Review 6.  The role of 18F-FDG PET CT in common gynaecological malignancies.

Authors:  Priya Narayanan; Anju Sahdev
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

7.  Clinical Value of Combining 18F-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma.

Authors:  Rajiv Rai Sookha; Wenhua Zhi; Yanxia Shen; Cordelle Lazare; Ling Wang; Yifan Meng; Canhui Cao; Junbo Hu; Peng Wu
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

8.  Anisakiasis mimics cancer recurrence: two cases of extragastrointestinal anisakiasis suspected to be recurrence of gynecological cancer on PET-CT and molecular biological investigation.

Authors:  Yuya Nogami; Yoko Fujii-Nishimura; Kouji Banno; Atsushi Suzuki; Nobuyuki Susumu; Taizo Hibi; Koji Murakami; Taketo Yamada; Hiromu Sugiyama; Yasuyuki Morishima; Daisuke Aoki
Journal:  BMC Med Imaging       Date:  2016-04-26       Impact factor: 1.930

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.